Table 2.
Final list of indicators post final global consultation.
| # | Indicator name | Numerator | Denominator | Comment: Core or Additional indicator |
|---|---|---|---|---|
| 1. Contraception (n=4) (Total core = 4) | ||||
| 1.1 | # of women accepting a modern contraceptive method in the facility | Total # of patients who accept a modern contraceptive method in the facility | N/A |
Core Need a denominator for 1.2 and aligns with the 2018 IAFM |
| 1.2 | % of women accepting a modern contraceptive method, by method (including EC, and by EC method) | # of women who accept a modern contraceptive method, by method (including EC, and by EC method) | Total # of women who accept a modern contraceptive method in the facility |
Core Notes need to make it clear that some women will request EC multiple times. |
| 1.3 | % of women accepting a modern contraceptive method, by method, after delivery and before discharge | # of women who accept a modern contraceptive method, by method, after delivery and before discharge | # of women delivering in the facility | Core |
| 1.4 | % of women accepting a modern contraceptive method after an abortion, by method | # of women who accept a modern contraceptive method after an abortion, by method | # of women receiving abortion services in the facility | Core |
| 2. Abortion (n=4) (Total core-4) | ||||
| 2.1 | Number of women requesting an abortion | # of women who request an abortion, by gestational age | N/A | Core |
| 2.2 | Number of women receiving an abortion referral | # of women who receive a referral for abortion care, by gestational age | N/A | Core |
| 2.3 | Number of women receiving an induced abortiona | # of women who obtain induced abortion care in the facility, by method and gestational age | N/A | Core |
| 2.4 | Number of women receiving post-abortion care | # of women who obtain post-abortion care, by method of treatment | N/A | Core |
| 3. Maternal health (n=17) (Total core = 7, Total additional/context-specific = 6, Total additional/service readiness = 4) | ||||
| 3.1 | Number of maternal deaths | # of maternal deathsb | N/A | Core |
| 3.2 | Are maternal deathsc reviewed? (Y/N) | Are maternal deaths reviewed (Yes/No) | N/A | Core |
| 3.3 | Number of women receiving at least 1 antenatal care visit | # of women with at least one antenatal care visit | N/A | Core |
| 3.4 | Number of women receiving four or more antenatal care visits | # of women with four or more antenatal care visits | N/A | Core |
| 3.5 | Number of deliveriesd | # of women delivering in a facility, including both live and stillbirths | N/A | Core |
| 3.6 | Number of women receiving post-natal care | # of women receiving postnatal care within 2 days | N/A | Core |
| 3.7 | Number of caesarean section deliveries | # of births by caesarean section | N/A | Core |
| 3.8 | Number of maternal deaths, disaggregated | # of maternal deaths2, disaggregated by age (less than 18 years; equal or greater than 18 years), cause, and timing | N/A | Additional/context-specific |
| 3.9 | Number of deliveries, disaggregated | # of women delivering ina facility, including both live and stillbirths, by age less than 18 years; equal or greater than 18 years | N/A |
Additional/context-specific Disaggregated by age of mother (<18, > 18; consider age 15 as additional if feasible) and outcome (live birth, stillbirth) |
| 3.10 | Number of antenatal care women with tetanus vaccination | # of women with TT2+ vaccination during antenatal care | N/A | Additional/Context-specific |
| 3.11 | Number of antenatal care women receiving preventive therapy for malaria | # of women receiving three or more doses of intermittent preventative therapy for malaria during pregnancy (IPTp) during antenatal care | N/A | Additional/Context-specific |
| 3.12 | Number of antenatal care women receiving syphilis screening | # of women receiving syphilis screening during antenatal care | N/A |
Additional/Context-specific Core under PMTCT domain |
| 3.13 | Number of antenatal care women receiving proteinuria testing | # of women receiving proteinuria testing during antenatal care | N/A | Additional/Context-specific |
| 3.14 | Availability of post-abortion care | # of facilities providing post-abortion care as part of emergency obstetric care services | N/A | Additional/Service readiness -assessed through periodic service availability assessment/ mapping not routine health data |
| 3.15 | Availability of basic emergency obstetric care (BEmOC) | # of facilities with delivery services that are able to provide all 7 signal functions of BEmOC | N/A | Additional/Service readiness- assessed through periodic service availability assessment/ mapping not routine health data |
| 3.16 | Availability of comprehensive emergency obstetric care (CEmOC) | # of facilities with delivery services that are able to provide all 9 signal functions of CEmOC | N/A | Additional/Service readiness - assessed through periodic service availability assessment/ mapping not routine health data |
| 3.17 | Availability of skilled personnel | # of health facilities with skilled health personnel available 24 h a day, 7 days a week | N/A | Additional/Service readiness -assessed through periodic service availability assessment/ mapping not routine health data |
| 4. Newborn health (n=14) (Total core = 7, Total additional/context-specific = 5, Total additional/service readiness = 2) | ||||
| 4.1 | Number of neonatal deaths | # of neonatal deaths (0 to 27 days, inclusive) | N/A | Core |
| 4.2 | Number of newborns receiving Hepatitis B | # of newborns that received Hepatitis B birth dose | N/A | Core |
| 4.3 | Number of newborns initiating breastfeeding within 1 h of brith | # of newborns breastfed within 1 h of birth or prior to discharge | N/A |
Core Tracer for essential newborn care, ENAP indicators |
| 4.4 | Number of stillbirths | # of fetuses and infants born per year with no sign of life and born after 28 weeks gestation or weighing ≥1000 g | N/A | Core |
| 4.5 | Number of babies born low birth weight | # of babies born less than 2500 g | N/A | Core |
| 4.6 | Newborns admitted for inpatient care | # of newborns admitted for inpatient care | N/A | Core |
| 4.7 | Number of newborns receiving post-natal care | # of newborns receiving post-natal care within 2 days | N/A | Core |
| 4.8 | Number of neonatal deaths, disaggregated |
# of newborn deaths, disaggregated by age (in days) at death and cause of death | N/A | Additional, context-specific |
| 4.9 | Are perinatal deathse reviewed? (Y/N) | Are perinatal deaths reviewed (Yes/No) | N/A | Additional, context-specific |
| 4.10 | Number of newborns who received any positive pressure ventilation using any device (Most commonly bag and mask) | # of newborns who received any positive pressure ventilation using any device (Most commonly bag and mask) | N/A | Additional, context-specific |
| 4.11 | Number of newborns receiving treatment for possible severe bacterial infection | # of newborns with possible severe bacterial infection (PSBI) that receive treatment (Ampicillin + Gentamycin) at least two days | N/A | Additional, context-specific |
| 4.12 | Number of newborns less than 2500 g receiving Kangaroo Mother Care | # of newborns less than 2500 g receiving Kangaroo Mother Care | Additional, context-specific | |
| 4.13 | Availability of kangaroo mother care | # of facilities that provide kangaroo mother care | N/A | Additional/Service readiness - assessed through periodic service availability assessment/ mapping not routine health data |
| 4.14 | Availability of neonatal resuscitation (most commonly bag and mask) | # of facilities with delivery services that provide neonatal resuscitation (most commonly bag and mask) | N/A |
Additional/Service readiness - assessed through periodic service availability assessment/ mapping, not routine health data Can be captured as part of BEmOC if we use BEmONC |
| 5. Child health (n=13) (Total core = 10, Additional context specific = 3) | ||||
| 5.1 | Number of deaths of children under 5 | # of deaths of children from 1 to 59 months | N/A |
Core Disaggregate by age, sex (facility-based, may include verbal autopsy for cause of death) |
| 5.2 | Under 5 mortality rate | # of deaths of children 1 to 59 months | Per 1000 children 1 to 59 months in catchment area |
Coref Poorly collected but very relevant; national indicator of many countries, SDG indicator Denominator issue (better in survey, not facility) but still needed in facilities and camp settings for monitoring; could use sentinel site or facility level population |
| 5.3 | Percentage of children under 5 with suspected acute respiratory infection taken to appropriate health facility | # of children under 5 years with suspected acute respiratory infection (cough and difficult breathing NOT due to a problem from a blocked nose) in the two weeks preceding the survey taken to an appropriate health facility or provider | Total number of children under 5 years with suspected acute respiratory infection (cough and difficult breathing NOT due to a problem from a blocked nose) in the two weeks preceding the survey |
Core Survey not facility; measuring care-seeking behaviour of caregivers which is key for appropriate treatment of and survival from pneumonia. Data from surveillance if exist. |
| 5.4 | Coverage of diarrhoea treatment | # of children under 5 with diarrhoea attending a facility and receiving fluid from ORS packets or pre-packaged ORS fluids and zinc supplement (as the latter is preferred) | # of children under 5 with diarrhoea attending the same facility over the same period |
Core Facility (more accurate than reported in survey) |
| 5.5 | Percentage of children under 5 who are wasted | # of children under 5 who are wasted (moderate and severe) | # of children under 5 in the catchment area |
Core This measures acute malnutrition and should be actionable |
| 5.6 | Number of children presenting with fever tested for malaria in endemic settings | # of children administered outpatient malaria tests, by age (under 5 years, 5–9 years) | N/A |
Core Malaria is a leading cause of under 5 death in malaria-endemic countries (it is important to reflect if the incidence is local or imported) |
| 5.7 | Percentage of confirmed malaria cases treated with an ACT | # of malaria cases treated with ACT x 100 | # of cases of diagnosed malaria, by age (under 5 years, 5–9 years) |
Core Numerator = 5.8 |
| 5.8 | Coverage of DPT3 | # of infants under 12 months who received 3 doses of DPT in a given time period | # of infants under 12 months in the catchment area |
Core National indicator for some countries Comparable, generalizable SDG covers more than DTP3 Preferable to be disaggregated by sex, community of origin as long as this information can be routinely captured |
| 5.9 | Percentage of anaemia in children & adolescents | # of children under 5 and adolescents who are anaemic | Total # of children under 5 and adolescents |
Core Leading cause of Years of Life Lived with disability (poor health; YLDs) Facility-based |
| 5.10 | Percentage of children under 5 who are registered | # of children under 5 whose births have been registered with a civil authority, by age | # of children under 5 in the catchment area, by age |
Additional, context-specific SDG indicator; Combine with birth registration Clarify on registration status Difficult to measure through health providers Survey helps |
| 5.11 | Number of confirmed cases of malaria in endemic settings | # of cases of confirmed malaria, by age (under 5 years, 5–9 years) | N/A |
Additional, context-specific Measures testing but can be captured through 5.9 |
| 5.12 | Percentage of children overweight | # of children under 5 who are overweight | Total # of children under 5 |
Additional, context-specific No added burden as it is the same weight, height, age, sex as wasting |
| 5.13 | Percentage of children stunted | # of children under 5 who are overweight | Total # of children under 5 |
Additional, context-specific No added burden as it is the same weight, height, age, sex as wasting |
| 6. Adolescent health (n=6) Total core =4, Total additional, context specific = 2 | ||||
| 6.1 | Adolescent birth rate | # of live births to adolescents age 10–14 or 15–19 | # of adolescents age 10–14 or 15–19 in the catchment area | Core |
| 6.2 | Adolescent mortality rate | # of deaths among adolescents aged 10–19 | # of adolescents age 10–19 in the catchment area |
Core Very difficult to collect If resources and population data are available/ if not, facility or sentinel site population could be used |
| 6.3 | Percentage of adolescents living with HIV who are currently receiving antiretroviral therapy, | # of adolescents living with HIV who are currently receiving antiretroviral therapy, disaggregated by age and sex | # of adolescents aged 10–19 living with HIV in the catchment area | Core |
| 6.4 | Immunization coverage rate | # of individuals in the target group for each vaccine in the national schedule that has received the last recommended dose in the basic series | # of in the target group for each vaccine | Core |
| 6.5 | Sexual violence against children and adolescents (disaggregate by age) | # of adults of age 18–29 reported as victims of sexual violence by age 18 | # of adults age 18–29 in the catchment area |
Additional, context-specific Very difficult to collect at the facility level Should be survey-based There is a sensitivity issue in data access |
| 6.6 | Suicide rate, disaggregated | # of suicide deaths in a year, disaggregated by age and sex | Per 100,000 patients in the catchment area | Additional, context-specific |
| 7. SGBV (n=6) Total core =4, Total additional, context-specific = 2 | ||||
| 7.1 | Number of rape survivors | # of rape survivors presenting at facility, by timeframe, sex, and age | N/A | Core |
| 7.2 | Number of intimate partner violence (IPV) survivors | # of cases of physical and/or sexual and/or psychological/emotional violence by a current or former partner reported by women to or identified by health care providers or at health care facilities, by age | N/A | Core |
| 7.3 | Percentage of health facilities with the clinical management of rape services | # of health facilities that can provide clinical management of rape services (as per WHO guidelines, in the form of the following services: (i) First line support, (ii) EC, (iii) presumptive treatment STI, (iv) HIV PEP, (v) access to abortion | # of health facilities in the catchment area |
Core Inclusion of abortion referral system and/or services to the extent that the law allows the service to be available |
| 7.4 | Percentage of rape and IPV survivors receiving first-line support | # of survivors of rape or IPV reported to or identified by health providers who receive first-line support, by sex and age | # of rape and IPV survivors reporting to/ identified by health providers |
Core First-line support is recommended by WHO to include: listening, inquiring, validating, enhancing safety, and support services (LIVES). This is also referred to as psychological first aid or can be in the form of psychosocial support/crises counselling. |
| 7.5 | Percentage of rape survivors receiving HIV post-exposure prophylaxis | # of rape survivors potentially exposed to HIV that receive post-exposure prophylaxis within 72 h of the incident, by sex and age | # of rape survivors presenting at facility | Additional, context-specific |
| 7.6 | Percentage of rape survivors receiving emergency contraception | # of rape survivors who receive emergency contraception within 120 h of incident, by method, by age | # of rape survivors presenting at facility | Additional, context-specific |
| 8. HIV/AIDS (n=5) Total core = 3, Total additional, context-specific = 2 | ||||
| 8.1 | Antiretroviral therapy coverage among patients living with HIV, disaggregated | # of adults and children living with HIV who are currently receiving antiretroviral combination therapy in accordance with the nationally approved treatment protocol, disaggregated by age and sex | # of adults and children living with HIV presenting at the facility |
Core This should be a minimum in every context – especially considering the mortality rate of HIV/AIDS in a humanitarian context, access to treatment may be limited Disaggregation by sex and gender |
| 8.2 | Percentage of exposed individuals receiving post-exposure prophylaxis within 72 h of the incidentg | # of individuals potentially exposed to HIV that receive post-exposure prophylaxis within 72 h of the incident | # of individuals potentially exposed to HIV presenting at the facility |
Core Clinical management of rape, as part of the minimum response An additional indicator monitoring emergency contraception for up to 5 days (where relevant), also STI prophylaxis for up to 2 weeks |
| 8.3 | Percentage of donated blood units screened for HIV in quality-assured manner | # of donated blood units screened for HIV in quality-assured manner | # of donated blood units |
Core Relevant at the Hospital level Higher-level health centre |
| 8.4 | Prevention of HIV among adolescents | Numerator enumeration is dependent on context and data availability | Denominator enumeration is dependent on context and data availability |
Additional, context-specific Harmonize the wording with UNAIDS/WHO guidelines |
| 8.5 | Indicators reflecting prevention of HIV (more relevant once situation has stabilized) | Numerator enumeration is dependent on context and data availability | Denominator enumeration is dependent on context and data availability |
Additional, context-specific Harmonize the wording with UNAIDS/WHO guidelines |
| 8.6 | Patients with TB offered HIV testing (more relevant once situation has stabilized) – major issue in humanitarian settings and a target of the global aid strategy | Numerator enumeration is dependent on context and data availability | Denominator enumeration is dependent on context and data availability |
Additional, context-specific Harmonize the wording with UNAIDS/WHO guidelines |
| 9. PMTCT (n=3) Total core =3 | ||||
| 9.1 | Percentage of antenatal care women offered testing for HIV | # of first time antenatal care women who received pre-test counselling | # of first time antenatal care women |
Core More relevant in stable humanitarian settings, where HIV is prevalent and screening services are available Not part of MISP |
| 9.2 | Percentage of HIV-positive pregnant women currently on antiretroviral therapy | # of HIV-positive pregnant women who currently on antiretroviral therapy to reduce the risk of mother-to-child transmission | # of HIV-positive pregnant women presenting at the facility |
Core More relevant in stable humanitarian settings, where HIV is prevalent and screening services are available Not part of MISP |
| 9.3 | Percentage of all deliveries to HIV-positive mothers receiving antiretrovirals | # of HIV-positive mothers where the mother-infant pair swallowed antiretrovirals according to protocol | # of HIV positive deliveries at facility |
Core More relevant in stable humanitarian settings, where HIV is prevalent and screening services are available Not part of MISP |
| 10. STIs/RTIs (n=1) Total core =1 | ||||
| 10.1 | Percentage of STI/RTI cases managed | # of patients with STI/RTI accessing services who are assessed, treated, and counselled according to protocol | # of STI/RTI patients accessing services |
Core Splitting up this indicator – STIs vs RTIs Syndromic cases are included in the MISP |
a
Need to clearly differentiate induced abortion care from post-abortion care
b
# of female deaths from any cause related to or aggravated by pregnancy or its management during pregnancy and childbirth or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy
c
Note this is just for deaths in health facilities. Will need to establish different reporting mechanisms.
d
Deliveries is defined as the number of pregnancies that end in a live or stillbirth
e
This is for all perinatal deaths in health facilities. Will need to establish different reporting mechanisms.
f
Estimates are available for all countries annually from the UN-IGME http://www.childmortality
g
This indicator is also needed to assess the need